- Home
- ATXS vs GBAB Comparison
ATXS vs GBAB Comparison
Compare ATXS & GBAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- GBAB
- Stock Information
- Founded
- ATXS 2008
- GBAB 2010
- Country
- ATXS United States
- GBAB United States
- Employees
- ATXS N/A
- GBAB N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- GBAB Investment Managers
- Sector
- ATXS Health Care
- GBAB Finance
- Exchange
- ATXS Nasdaq
- GBAB Nasdaq
- Market Cap
- ATXS 401.2M
- GBAB 400.4M
- IPO Year
- ATXS 2015
- GBAB N/A
- Fundamental
- Price
- ATXS $6.65
- GBAB $14.92
- Analyst Decision
- ATXS Strong Buy
- GBAB
- Analyst Count
- ATXS 7
- GBAB 0
- Target Price
- ATXS $32.43
- GBAB N/A
- AVG Volume (30 Days)
- ATXS 304.1K
- GBAB 69.4K
- Earning Date
- ATXS 08-11-2025
- GBAB 01-01-0001
- Dividend Yield
- ATXS N/A
- GBAB 9.18%
- EPS Growth
- ATXS N/A
- GBAB N/A
- EPS
- ATXS N/A
- GBAB N/A
- Revenue
- ATXS N/A
- GBAB N/A
- Revenue This Year
- ATXS N/A
- GBAB N/A
- Revenue Next Year
- ATXS N/A
- GBAB N/A
- P/E Ratio
- ATXS N/A
- GBAB N/A
- Revenue Growth
- ATXS N/A
- GBAB N/A
- 52 Week Low
- ATXS $3.56
- GBAB $14.22
- 52 Week High
- ATXS $12.92
- GBAB $17.44
- Technical
- Relative Strength Index (RSI)
- ATXS 60.88
- GBAB 48.89
- Support Level
- ATXS $5.94
- GBAB $14.79
- Resistance Level
- ATXS $6.49
- GBAB $15.08
- Average True Range (ATR)
- ATXS 0.34
- GBAB 0.23
- MACD
- ATXS -0.00
- GBAB -0.02
- Stochastic Oscillator
- ATXS 74.74
- GBAB 18.06
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust of Beneficial Interest
Guggenheim Taxable Municipal Managed Duration Trust is a diversified closed-end management investment company. Its investment objective is to provide current income with a secondary objective of long-term capital appreciation. Its products include Mutual funds, Unit investment trusts, Closed-end funds, Rydex funds, Credit income fund and others.